Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
1,5-dihydroxyisoquinoline | [no description available] | medium | 1 | 0 | isoquinolinol | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
3-aminobenzamide | [no description available] | medium | 1 | 0 | benzamides; substituted aniline | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
4-amino-1,8-naphthalimide | [no description available] | medium | 1 | 0 | benzoisoquinoline; dicarboximide | |
phenanthridone | [no description available] | medium | 1 | 0 | lactam; phenanthridines | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; immunosuppressive agent; mutagen |
benzamide | [no description available] | medium | 1 | 0 | benzamides | |
1-hydroxyphthalazine | [no description available] | medium | 1 | 0 | phthalazines | |
isocarbostyril | [no description available] | medium | 1 | 0 | isoquinolines | |
2,4(1h,3h)-quinazolinedione | [no description available] | medium | 1 | 0 | | |
4-hydroxybenzamide | [no description available] | medium | 1 | 0 | | |
naphthalimides | [no description available] | medium | 1 | 0 | | |
4-fluorobenzamide | [no description available] | medium | 1 | 0 | | |
4-aminobenzamide | [no description available] | medium | 1 | 0 | benzamides | |
3-methoxybenzamide | [no description available] | medium | 1 | 0 | | |
3,4-dihydro-5-methyl-1(2h)-isoquinolinone | [no description available] | medium | 1 | 0 | isoquinolines | |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone | [no description available] | medium | 1 | 0 | | |
nu 1025 | [no description available] | medium | 1 | 0 | phenols; quinazolines | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
2-methyl-4(3h)-quinazolinone | [no description available] | medium | 1 | 0 | | |
4-hydroxyquinazoline | [no description available] | medium | 1 | 0 | quinazolines | |
formaldehyde | [no description available] | medium | 1 | 0 | aldehyde; one-carbon compound | allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
aminopyrine | [no description available] | medium | 1 | 0 | pyrazolone; tertiary amino compound | antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
amobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
azasetron | [no description available] | low | 0 | 0 | benzoxazine | |
2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | aromatic ether; benzoxazine; cyclic hydroxamic acid; lactol | allelochemical; plant metabolite |
bentranil | [no description available] | low | 0 | 0 | benzoxazine | herbicide |
carsalam | [no description available] | low | 0 | 0 | benzoxazine | |
n-methylisatoic anhydride | [no description available] | low | 0 | 0 | benzoxazine | |
2,4-dihydroxy-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | benzoxazine; cyclic hydroxamic acid; lactol | allelochemical; herbicide; phytotoxin; plant metabolite |
caroxazone | [no description available] | low | 0 | 0 | benzoxazine | |
benoxacor | [no description available] | low | 0 | 0 | benzoxazine | |
efavirenz | [no description available] | low | 0 | 0 | acetylenic compound; benzoxazine; cyclopropanes; organochlorine compound; organofluorine compound | antiviral drug; HIV-1 reverse transcriptase inhibitor |
s 53482 | [no description available] | low | 0 | 0 | benzoxazine; dicarboximide; organofluorine compound; terminal acetylenic compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide; teratogenic agent |
2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | benzoxazine | |
2-(3-nitrophenyl)-3,1-benzoxazin-4-one | [no description available] | low | 0 | 0 | benzoxazine | |
2-hydroxy-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | benzoxazine; lactam; lactol | allelochemical; plant metabolite |
2-[2,2-dimethyl-6-[4-morpholinyl(oxo)methyl]-3-oxo-1,4-benzoxazin-4-yl]-N-phenylacetamide | [no description available] | low | 0 | 0 | benzoxazine | |
2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-[(5-methyl-2-furanyl)methyl]-N-(3-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | benzoxazine | |
2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-(thiophen-2-ylmethyl)acetamide | [no description available] | low | 0 | 0 | benzoxazine | |
N-[4-(4-oxo-2,3-dihydro-1,3-benzoxazin-2-yl)phenyl]acetamide | [no description available] | low | 0 | 0 | benzoxazine | |
2-(2,3,4-trimethoxyphenyl)-2,3-dihydro-1,3-benzoxazin-4-one | [no description available] | low | 0 | 0 | benzoxazine | |
3-methyl-N-[4-(4-oxo-3,1-benzoxazin-2-yl)phenyl]butanamide | [no description available] | low | 0 | 0 | benzoxazine | |
acetic acid [2-(2-methylphenyl)-4-oxo-3,1-benzoxazin-7-yl] ester | [no description available] | low | 0 | 0 | benzoxazine | |
6-hydroxy-2-(4-nitrophenyl)-3,1-benzoxazin-4-one | [no description available] | low | 0 | 0 | benzoxazine | |
3-phenyl-2H-1,4-benzoxazine | [no description available] | low | 0 | 0 | benzoxazine | |
6-[1-oxo-2-[[4-(phenylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]ethyl]-4H-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | benzoxazine | |
2-(5-bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one | [no description available] | low | 0 | 0 | benzoxazine | |
3-chloro-1-benzothiophene-2-carboxylic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester | [no description available] | low | 0 | 0 | benzoxazine | |
2-(tert-butyl)-6,7-dimethoxy-4H-3,1-benzoxazin-4-one | [no description available] | low | 0 | 0 | benzoxazine | |
6-[2-(2-methoxyphenyl)imino-3-(2-oxolanylmethyl)-4-thiazolyl]-4H-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | benzoxazine | |
4-[(3-oxo-4H-1,4-benzoxazin-7-yl)sulfonyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | benzoxazine | |
N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-2-(3-oxo-1,4-benzoxazin-4-yl)acetamide | [no description available] | low | 0 | 0 | benzoxazine | |
acetic acid [3-oxo-2-(trifluoromethyl)-4H-1,4-benzoxazin-2-yl] ester | [no description available] | low | 0 | 0 | benzoxazine | |
2-(3-thiophenyl)acetic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester | [no description available] | low | 0 | 0 | benzoxazine | |
4-(dimethylsulfamoyl)benzoic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester | [no description available] | low | 0 | 0 | benzoxazine | |
6-[2-butylimino-3-(cyclopentylideneamino)-4-thiazolyl]-4H-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | benzoxazine | |
N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-3-(3-oxo-1,4-benzoxazin-4-yl)propanamide | [no description available] | low | 0 | 0 | benzoxazine | |
2-[4-[(4-chlorophenyl)-oxomethyl]-2,3-dihydro-1,4-benzoxazin-3-yl]acetic acid methyl ester | [no description available] | low | 0 | 0 | benzoxazine | |
3-(2,6-dimethyl-3-oxo-1,4-benzoxazin-4-yl)-N-(thiophen-2-ylmethyl)propanamide | [no description available] | low | 0 | 0 | benzoxazine | |
N-[(4-tert-butylphenyl)methyl]-3-oxo-4H-1,4-benzoxazine-6-carboxamide | [no description available] | low | 0 | 0 | benzoxazine | |
cetilistat | [no description available] | low | 0 | 0 | benzoxazine | |
rs 102895 | [no description available] | low | 0 | 0 | benzoxazine | |
olodaterol | [no description available] | low | 0 | 0 | aromatic ether; benzoxazine; phenols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent |
4-(6-chloro-2-methyl-2,3-dihydro-1,4-benzoxazin-4-yl)-4-oxo-N-(phenylmethyl)butanamide | [no description available] | low | 0 | 0 | benzoxazine | |
N-[(4-fluorophenyl)methyl]-2-[3-oxo-6-(1-piperidinylsulfonyl)-1,4-benzoxazin-4-yl]acetamide | [no description available] | low | 0 | 0 | benzoxazine | |
N-(3,5-dimethoxyphenyl)-6-methyl-3-oxo-4H-1,4-benzoxazine-7-sulfonamide | [no description available] | low | 0 | 0 | benzoxazine | |
etifoxine | [no description available] | low | 0 | 0 | benzoxazine | |